Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.920
+0.200 (11.63%)
At close: Apr 8, 2026, 4:00 PM EDT
1.890
-0.030 (-1.56%)
After-hours: Apr 8, 2026, 7:44 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $81.92 million as of April 8, 2026. Its market cap has increased by 124.18% in one year.
Market Cap
81.92M
Enterprise Value
80.54M
1-Year Change
124.18%
Ranking
Category
Stock Price
$1.92
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $81.92M, an increase of 4,508.31%. That is a compound annual growth rate of 201.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 73.38M | 24.56% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pelthos Therapeutics | 76.31M |
| Fortress Biotech | 75.68M |
| NRx Pharmaceuticals | 73.67M |
| Cognition Therapeutics | 73.04M |
| iBio, Inc. | 72.89M |
| MAIA Biotechnology | 72.81M |
| Impact BioMedical | 72.18M |
| Fractyl Health | 71.46M |